Susan Mahony, SVP & President, Lilly Oncology at LILLY ELI & CO (LLY), sold 15,777 shares at $54.28 ($850K) on 2013-02-01, disclosed to the SEC on 2013-02-04.
Scheduled sale ($850k) by SVP & President, Lilly Oncology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.69 | 10,777 | $579K | 68.1% |
| 2 | $54.28 | 5,000 | $271K | 31.9% |
| Total | $53.88 avg | 15,777 | $850K | 100% |
| Filing → |
| LLY | SELL | 2017-12-05 | $6.3M | — | Filing → |
| LLY | SELL | 2016-12-19 | $2.9M | — | Filing → |
| LLY | SELL | 2015-07-29 | $2.1M | — | Filing → |